CH656308A5 - Compositions pharmaceutiques contenant du salbutamol. - Google Patents
Compositions pharmaceutiques contenant du salbutamol. Download PDFInfo
- Publication number
- CH656308A5 CH656308A5 CH2779/83A CH277983A CH656308A5 CH 656308 A5 CH656308 A5 CH 656308A5 CH 2779/83 A CH2779/83 A CH 2779/83A CH 277983 A CH277983 A CH 277983A CH 656308 A5 CH656308 A5 CH 656308A5
- Authority
- CH
- Switzerland
- Prior art keywords
- pharmaceutical composition
- cellulose
- composition according
- salbutamol
- liquid
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title claims description 23
- NDAUXUAQIAJITI-UHFFFAOYSA-N albuterol Chemical compound CC(C)(C)NCC(O)C1=CC=C(O)C(CO)=C1 NDAUXUAQIAJITI-UHFFFAOYSA-N 0.000 title claims description 19
- 229960002052 salbutamol Drugs 0.000 title claims description 16
- 229920002678 cellulose Polymers 0.000 claims description 19
- 239000001913 cellulose Substances 0.000 claims description 19
- 150000003839 salts Chemical class 0.000 claims description 11
- 239000007788 liquid Substances 0.000 claims description 9
- 239000001866 hydroxypropyl methyl cellulose Chemical class 0.000 claims description 7
- 229920003088 hydroxypropyl methyl cellulose Chemical class 0.000 claims description 7
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims description 7
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical class OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 claims description 7
- 238000002360 preparation method Methods 0.000 claims description 7
- 229920000663 Hydroxyethyl cellulose Chemical class 0.000 claims description 5
- 239000004354 Hydroxyethyl cellulose Chemical class 0.000 claims description 5
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 claims description 5
- 229920002134 Carboxymethyl cellulose Chemical class 0.000 claims description 3
- 239000001768 carboxy methyl cellulose Chemical class 0.000 claims description 3
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims description 3
- 239000008112 carboxymethyl-cellulose Chemical class 0.000 claims description 3
- 239000006185 dispersion Substances 0.000 claims description 3
- 239000001856 Ethyl cellulose Substances 0.000 claims description 2
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical class CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 claims description 2
- 229920001479 Hydroxyethyl methyl cellulose Chemical class 0.000 claims description 2
- 229920002153 Hydroxypropyl cellulose Chemical class 0.000 claims description 2
- 125000000217 alkyl group Chemical group 0.000 claims description 2
- 229920001249 ethyl cellulose Polymers 0.000 claims description 2
- 235000019325 ethyl cellulose Nutrition 0.000 claims description 2
- 239000001761 ethyl methyl cellulose Chemical class 0.000 claims description 2
- 235000010944 ethyl methyl cellulose Nutrition 0.000 claims description 2
- 229920013819 hydroxyethyl ethylcellulose Chemical class 0.000 claims description 2
- 229920003063 hydroxymethyl cellulose Chemical class 0.000 claims description 2
- 229940031574 hydroxymethyl cellulose Drugs 0.000 claims description 2
- 239000001863 hydroxypropyl cellulose Chemical class 0.000 claims description 2
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 claims description 2
- 229920000609 methyl cellulose Chemical class 0.000 claims description 2
- 239000001923 methylcellulose Chemical class 0.000 claims description 2
- 235000010981 methylcellulose Nutrition 0.000 claims description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims 1
- 239000012458 free base Substances 0.000 claims 1
- -1 hydroxyalkyl ether Chemical compound 0.000 claims 1
- 239000000203 mixture Substances 0.000 description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 13
- BNPSSFBOAGDEEL-UHFFFAOYSA-N albuterol sulfate Chemical compound OS(O)(=O)=O.CC(C)(C)NCC(O)C1=CC=C(O)C(CO)=C1.CC(C)(C)NCC(O)C1=CC=C(O)C(CO)=C1 BNPSSFBOAGDEEL-UHFFFAOYSA-N 0.000 description 6
- 238000009472 formulation Methods 0.000 description 6
- YASYEJJMZJALEJ-UHFFFAOYSA-N Citric acid monohydrate Chemical compound O.OC(=O)CC(O)(C(O)=O)CC(O)=O YASYEJJMZJALEJ-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 229960002303 citric acid monohydrate Drugs 0.000 description 3
- 238000001246 colloidal dispersion Methods 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000013355 food flavoring agent Nutrition 0.000 description 2
- 235000003599 food sweetener Nutrition 0.000 description 2
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 2
- 239000001509 sodium citrate Substances 0.000 description 2
- 229960000999 sodium citrate dihydrate Drugs 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 239000003765 sweetening agent Substances 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 description 2
- FTLYMKDSHNWQKD-UHFFFAOYSA-N (2,4,5-trichlorophenyl)boronic acid Chemical compound OB(O)C1=CC(Cl)=C(Cl)C=C1Cl FTLYMKDSHNWQKD-UHFFFAOYSA-N 0.000 description 1
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- UDIPTWFVPPPURJ-UHFFFAOYSA-M Cyclamate Chemical compound [Na+].[O-]S(=O)(=O)NC1CCCCC1 UDIPTWFVPPPURJ-UHFFFAOYSA-M 0.000 description 1
- WINXNKPZLFISPD-UHFFFAOYSA-M Saccharin sodium Chemical compound [Na+].C1=CC=C2C(=O)[N-]S(=O)(=O)C2=C1 WINXNKPZLFISPD-UHFFFAOYSA-M 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 229920013820 alkyl cellulose Polymers 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 239000013011 aqueous formulation Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000000337 buffer salt Substances 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 229960004106 citric acid Drugs 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 239000000625 cyclamic acid and its Na and Ca salt Substances 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 229920013821 hydroxy alkyl cellulose Polymers 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 229940085605 saccharin sodium Drugs 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 229960001462 sodium cyclamate Drugs 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8215502 | 1982-05-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH656308A5 true CH656308A5 (fr) | 1986-06-30 |
Family
ID=10530673
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH2779/83A CH656308A5 (fr) | 1982-05-27 | 1983-05-20 | Compositions pharmaceutiques contenant du salbutamol. |
Country Status (25)
| Country | Link |
|---|---|
| JP (1) | JPH0629181B2 (de) |
| AT (1) | AT390191B (de) |
| AU (1) | AU567675B2 (de) |
| BE (1) | BE896870A (de) |
| CA (1) | CA1203176A (de) |
| CH (1) | CH656308A5 (de) |
| DE (1) | DE3319356C2 (de) |
| DK (1) | DK167558B1 (de) |
| ES (1) | ES522752A0 (de) |
| FI (1) | FI81257C (de) |
| FR (1) | FR2527442B1 (de) |
| GR (1) | GR82681B (de) |
| IE (1) | IE55139B1 (de) |
| IL (1) | IL68805A0 (de) |
| IT (1) | IT1174759B (de) |
| LU (1) | LU84828A1 (de) |
| MY (1) | MY8700275A (de) |
| NL (1) | NL192663C (de) |
| NO (1) | NO163166C (de) |
| NZ (1) | NZ204385A (de) |
| PH (1) | PH19601A (de) |
| PT (1) | PT76773B (de) |
| SE (1) | SE454946B (de) |
| ZA (1) | ZA833854B (de) |
| ZW (1) | ZW11883A1 (de) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3624213A (en) * | 1963-10-30 | 1971-11-30 | Merck & Co Inc | Method of sterilizing aqueous pharmaceutical solutions employing propylene oxide and entrained air |
| GB1200886A (en) * | 1966-09-23 | 1970-08-05 | Allen & Hanburys Ltd | Phenylaminoethanol derivatives |
| GB1453034A (en) * | 1972-12-15 | 1976-10-20 | Boehringer Sohn Ingelheim | Pharmaceutical composition for treating spasticity |
| JPS5831210B2 (ja) * | 1973-04-09 | 1983-07-05 | 武田薬品工業株式会社 | アンテイナスイセイケンダクエキノセイゾウホウ |
| DE2714065A1 (de) * | 1977-03-30 | 1978-10-12 | Boehringer Mannheim Gmbh | Instillationszubereitung |
-
1983
- 1983-05-20 CH CH2779/83A patent/CH656308A5/fr not_active IP Right Cessation
- 1983-05-24 GR GR71454A patent/GR82681B/el unknown
- 1983-05-26 NO NO831875A patent/NO163166C/no not_active IP Right Cessation
- 1983-05-26 FR FR8308722A patent/FR2527442B1/fr not_active Expired
- 1983-05-27 PT PT76773A patent/PT76773B/pt unknown
- 1983-05-27 ZA ZA833854A patent/ZA833854B/xx unknown
- 1983-05-27 PH PH28974A patent/PH19601A/en unknown
- 1983-05-27 LU LU84828A patent/LU84828A1/fr unknown
- 1983-05-27 DE DE3319356A patent/DE3319356C2/de not_active Expired - Lifetime
- 1983-05-27 DK DK241783A patent/DK167558B1/da not_active IP Right Cessation
- 1983-05-27 IT IT48384/83A patent/IT1174759B/it active Protection Beyond IP Right Term
- 1983-05-27 CA CA000429095A patent/CA1203176A/en not_active Expired
- 1983-05-27 IL IL68805A patent/IL68805A0/xx not_active IP Right Cessation
- 1983-05-27 BE BE0/210866A patent/BE896870A/fr not_active IP Right Cessation
- 1983-05-27 AU AU15039/83A patent/AU567675B2/en not_active Expired
- 1983-05-27 SE SE8303012A patent/SE454946B/sv not_active IP Right Cessation
- 1983-05-27 ES ES522752A patent/ES522752A0/es active Granted
- 1983-05-27 AT AT0195283A patent/AT390191B/de not_active IP Right Cessation
- 1983-05-27 NL NL8301900A patent/NL192663C/nl not_active IP Right Cessation
- 1983-05-27 NZ NZ204385A patent/NZ204385A/en unknown
- 1983-05-27 FI FI831893A patent/FI81257C/fi not_active IP Right Cessation
- 1983-05-27 JP JP58093896A patent/JPH0629181B2/ja not_active Expired - Lifetime
- 1983-05-27 IE IE1267/83A patent/IE55139B1/en not_active IP Right Cessation
- 1983-05-27 ZW ZW118/83A patent/ZW11883A1/xx unknown
-
1987
- 1987-12-30 MY MY275/87A patent/MY8700275A/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FR2464714A1 (fr) | Composition pharmaceutique topique contenant de la triethylenetetramine | |
| FR2560523A1 (fr) | Solution ophtalmique contenant du pranoprofene et de l'acide borique | |
| BE1000624A5 (fr) | Composition pharmaceutique contenant de la ranitidine. | |
| BG63031B1 (bg) | Противовъзпалителни състави,съдържащи пироксикам,за локално приложение | |
| CA1242458A (fr) | Ethers-oxydes et ethers-oximes d'alcoylaminoalcools comme medicaments, produits nouveaux et procedes pour leur preparation | |
| JPH0327532B2 (de) | ||
| FR2609394A1 (fr) | Solution aqueuse contenant un acide quinolone carboxylique | |
| US4594359A (en) | Pharmaceutical compositions | |
| CH656308A5 (fr) | Compositions pharmaceutiques contenant du salbutamol. | |
| WO1996014840A1 (en) | Use of menthyl lactate as a pain reliever | |
| EP0445540B1 (de) | Antimykotische Imidazol enthaltende Zubereitung zur äusserlichen Anwendung | |
| GB2120942A (en) | Salbutamol compositions | |
| HUT63060A (en) | Process for producing pharmaceutical compositions locally applicable on nose and eye, comprising bradykinin antagonists | |
| US5061486A (en) | Dithranol composition containing no oily ingredients | |
| CH638975A5 (fr) | Composition medicamenteuse pour le traitement des ulceres gastro-duodenaux. | |
| JP4156793B2 (ja) | デキサメタゾンゲル | |
| JPS5899414A (ja) | アルド−スレダクタ−ゼの阻害剤 | |
| EP1248652B1 (de) | Stabile wässrige lösung von deoxyfructosazine | |
| JP2613113B2 (ja) | イミダゾール系抗真菌性クリーム製剤 | |
| JPH0832626B2 (ja) | アズレン系抗炎症剤 | |
| CA2222566A1 (en) | Hydrogels that contain sorbic acid | |
| JPS647967B2 (de) | ||
| Rodu et al. | In vitro virucidal activity components of a forming medication | |
| FR2707163A1 (fr) | Composition hydroalcoolique contenant un parfum. | |
| JPH0224249B2 (de) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PL | Patent ceased |